T. Rowe Price Investment Management, Inc. Nkarta, Inc. Transaction History
T. Rowe Price Investment Management, Inc.
- $163 Billion
- Q1 2024
A detailed history of T. Rowe Price Investment Management, Inc. transactions in Nkarta, Inc. stock. As of the latest transaction made, T. Rowe Price Investment Management, Inc. holds 1,355,321 shares of NKTX stock, worth $7.02 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
1,355,321
Previous 462,838
192.83%
Holding current value
$7.02 Million
Previous $3.06 Million
379.61%
% of portfolio
0.01%
Previous 0.0%
Shares
7 transactions
Others Institutions Holding NKTX
# of Institutions
121Shares Held
52.8MCall Options Held
145KPut Options Held
114K-
Boxer Capital, LLC San Diego, CA5.61MShares$29 Million3.15% of portfolio
-
Deerfield Management Company, L.P. (Series C) New York, NY5.19MShares$26.9 Million1.16% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA3.8MShares$19.7 Million0.08% of portfolio
-
Samsara Bio Capital, LLC Palo Alto, CA3.77MShares$19.5 Million12.85% of portfolio
-
Nea Management Company, LLC Timonium, MD3.57MShares$18.5 Million2.71% of portfolio
About Nkarta, Inc.
- Ticker NKTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 48,656,800
- Market Cap $252M
- Description
- Nkarta, Inc., a a clinical-stage biopharmaceutical company, develops and commercializes cell therapies for cancer treatment. The company's approach for cellular immunotherapy involves chimeric antigen receptors on the surface of a natural killer (NK) cell that enable the cell to recognize specific proteins or antigens that are present on the sur...